EUVIMEDEUVIMED entdecken
Crossref

Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma

E. Gjersdal, L.B. Larsen, K.S. Ettrup, P. Vestergaard, E.H. Nielsen, J.S. Karmisholt, H.L. Muller, J. Dal

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.1.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von E. Gjersdal und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gjersdal, E., Larsen, L., Ettrup, K., Vestergaard, P., Nielsen, E., Karmisholt, J., Muller, H., & Dal, J. (2025). Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.1.12

Vancouver

Gjersdal E, Larsen L, Ettrup K, Vestergaard P, Nielsen E, Karmisholt J, et al. Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.1.12

BibTeX
@article{Gjersdal2025,
  author = {Gjersdal, E. and Larsen, L.B. and Ettrup, K.S. and Vestergaard, P. and Nielsen, E.H. and Karmisholt, J.S. and Muller, H.L. and Dal, J.},
  title = {Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.1.12}
}
Kostenlos starten →